| Stage | MGRC | % of rev | CXT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $275M | 100.00% | $497M | 100.00% | CXT ×1.81 |
| Gross profit | $131M | 47.66% | $198M | 39.81% | MGRC +7.8pp |
| Operating income | $74M | 26.93% | $66M | 13.22% | MGRC +13.7pp |
| Pre-tax income | $66M | 24.02% | $49M | 9.90% | MGRC +14.1pp |
| Net income | $49M | 17.77% | $39M | 7.87% | MGRC +9.9pp |
| Stage | MGRC | CXT | Gap · A − B |
|---|---|---|---|
| Revenue | $275M100.00% | $497M100.00% | CXT ×1.81 |
| Gross profit | 47.66%$131M | 39.81%$198M | MGRC +7.8pp |
| Operating income | 26.93%$74M | 13.22%$66M | MGRC +13.7pp |
| Pre-tax income | 24.02%$66M | 9.90%$49M | MGRC +14.1pp |
| Net income |
| 17.77%$49M |
| 7.87%$39M |
| MGRC +9.9pp |
No shared counterparties.